| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
phenotype | 0.300 | None | 1.000 | 4 | 0 | 1979 | 2010 | ||||||||
|
adenosine A2a receptor | 0.526 | 0.769 | 0.60 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 2004 | 2006 | ||||||||
|
Fos proto-oncogene, AP-1 transcription factor subunit | 0.411 | 0.885 | 0.26 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 2004 | 2008 | ||||||||
|
opioid receptor kappa 1 | 0.555 | 0.615 | 4.1E-05 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 1998 | 2010 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2004 | 2009 | ||||||||
|
glutamate ionotropic receptor AMPA type subunit 1 | 0.570 | 0.577 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2001 | 2003 | ||||||||
|
period circadian regulator 2 | 0.488 | 0.846 | 0.71 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2010 | 2010 | ||||||||
|
cholecystokinin B receptor | 0.573 | 0.615 | 2.1E-06 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 1998 | 2002 | ||||||||
|
fatty acid amide hydrolase | 0.545 | 0.692 | 4.4E-11 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2008 | 2009 | ||||||||
|
prepronociceptin | 0.603 | 0.577 | 1.5E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
period circadian regulator 1 | 0.556 | 0.731 | 2.9E-04 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
opioid related nociceptin receptor 1 | 0.628 | 0.462 | 0.48 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
opioid receptor delta 1 | 0.604 | 0.731 | 3.3E-03 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 1985 | 1985 | ||||||||
|
neuropeptide Y receptor Y2 | 0.612 | 0.577 | 3.6E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
neuronal pentraxin 2 | 0.617 | 0.615 | 3.1E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
arginine vasopressin | 0.437 | 0.846 | 7.4E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 1985 | 1985 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
period circadian regulator 3 | 0.559 | 0.731 | 1.4E-17 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
RUNX family transcription factor 2 | 0.437 | 0.846 | 0.95 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
tachykinin receptor 1 | 0.502 | 0.885 | 3.8E-04 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
solute carrier family 6 member 1 | 0.592 | 0.538 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2003 | 2003 |